KLOW – BPC‑157 10mg + TB‑500 10mg + GHK‑Cu 50mg + KPV 10mg

Description

KLOW is a four-peptide research blend combining GHK-Cu (50 mg), KPV (10 mg), BPC-157 (10 mg), and TB-500 (10 mg), 80 mg total. KPV is a tripeptide fragment related to α-MSH. Supplied lyophilized in a sealed vial.

Research context: In published laboratory and preclinical research, the individual components have been studied in the context of extracellular-matrix remodeling, cell migration, and NF-κB-associated inflammatory-signaling pathways; the complete blend has no established preclinical or clinical characterization.

Specifications: 80 mg total lyophilized blend (GHK-Cu 50 mg, KPV 10 mg, BPC-157 10 mg, TB-500 10 mg) in a sealed vial.

This product is supplied strictly for in-vitro laboratory research. It is not a drug, food, cosmetic, or dietary supplement, and is not intended for human or animal consumption, medical, veterinary, or household use.